Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2025-12-25 @ 10:47 PM
Study NCT ID:
NCT05932667
Status:
TERMINATED
Last Update Posted:
2023-12-21
First Post:
2023-06-13
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Milademetan and Fulvestrant in GATA3-mutant, ER+HER- Advanced or Metastatic Breast Cancer
Sponsor:
Institut Curie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-12
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-30
Completion Date Type:
ACTUAL
First Submit Date:
2023-06-13
First Submit QC Date:
None
Study First Post Date:
2023-07-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-20
Last Update Post Date:
2023-12-21
Last Update Post Date Type:
ACTUAL